{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:16:23Z","timestamp":1752671783836},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:00:00Z","timestamp":1350518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00774-012-0391-z","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T19:46:12Z","timestamp":1350503172000},"page":"116-122","source":"Crossref","is-referenced-by-count":12,"title":["Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Sakura","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahoko","family":"Sekiguchi-Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Hoshinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyasu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,18]]},"reference":[{"key":"391_CR1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725\u20131730","journal-title":"N Engl J Med"},{"key":"391_CR2","doi-asserted-by":"crossref","unstructured":"Ebeling PR (2008) Transplantation osteoporosis. In: Rosen CJ (eds) Primer on the metabolic diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington DC, pp 279\u2013285","DOI":"10.1002\/9780470623992.ch61"},{"key":"391_CR3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00007890-199410270-00009","volume":"58","author":"WH Grotz","year":"1994","unstructured":"Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ (1994) Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients. Transplantation 58:912\u2013915","journal-title":"Transplantation"},{"key":"391_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/oxfordjournals.ndt.a027341","volume":"11","author":"G Coen","year":"1996","unstructured":"Coen G (1996) Fracturing osteoporosis after kidney transplantation\u2014what are the options? Nephrol Dial Transplant 11:567\u2013569","journal-title":"Nephrol Dial Transplant"},{"key":"391_CR5","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/00007890-200012270-00011","volume":"70","author":"AV Cayco","year":"2000","unstructured":"Cayco AV, Wysolmerski J, Simpson C, Mitnick MA, Gundberg C, Kliger A, Lorber M, Silver D, Basadonna G, Friedman A, Insogna K, Cruz D, Bia M (2000) Posttransplant bone disease: evidence for a high bone resorption state. Transplantation 70:1722\u20131728","journal-title":"Transplantation"},{"key":"391_CR6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1432-2277.2008.00665.x","volume":"21","author":"C Mitterbauer","year":"2008","unstructured":"Mitterbauer C, Oberbauer R (2008) Bone disease after kidney transplantation. Transplant Int 21:615\u2013624","journal-title":"Transplant Int"},{"key":"391_CR7","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 113:S1\u2013S130","journal-title":"Kidney Int"},{"key":"391_CR8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0889-8529(05)70014-1","volume":"27","author":"NB Watts","year":"1998","unstructured":"Watts NB (1998) Treatment of osteoporosis with bisphosphonates. Endocrinol Metab Clin North Am 27:419\u2013439","journal-title":"Endocrinol Metab Clin North Am"},{"key":"391_CR9","doi-asserted-by":"crossref","unstructured":"Papapoulos SE (2008) Bisphosphonates for postmenopausal osteoporosis. In: Rosen CJ (eds) Primer on the metabolic diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington DC, pp 237\u2013241","DOI":"10.1002\/9780470623992.ch49"},{"key":"391_CR10","doi-asserted-by":"crossref","unstructured":"Weinstein RS (2008) Glucocorticoid-induced osteoporosis. In: Rosen CJ (eds) Primer on the metabolic diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington DC, pp 267\u2013272","DOI":"10.1002\/9780470623992.ch58"},{"key":"391_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bone.2011.02.011","volume":"49","author":"R Eastell","year":"2011","unstructured":"Eastell R, Walsh JS, Watts NB, Siris E (2011) Bisphosphonates for postmenopausal osteoporosis. Bone 49:82\u201388","journal-title":"Bone"},{"key":"391_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-004-0596-x","volume":"23","author":"H Nawata","year":"2005","unstructured":"Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y, Subcommittee to Study Diagnostic Criteria for Glucocorticoid-Induced Osteoporosis (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23:105\u2013109","journal-title":"J Bone Miner Metab"},{"key":"391_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2008.11.022","volume":"62","author":"J Compston","year":"2009","unstructured":"Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, Wilkins M, National Osteoporosis Guideline Group (NOGG) (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50\u00a0years in the UK. Maturitas 62:105\u2013108","journal-title":"Maturitas"},{"key":"391_CR14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62:1515\u20131526","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"391_CR15","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/jbmr.362","volume":"26","author":"KE Hansen","year":"2011","unstructured":"Hansen KE, Wilson HA, Zapalowski C, Fink HA, Minisola S, Adler RA (2011) Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Miner Res 26:1989\u20131996","journal-title":"J Bone Miner Res"},{"key":"391_CR16","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1359\/jbmr.2001.16.11.2111","volume":"16","author":"S Giannini","year":"2001","unstructured":"Giannini S, D\u2019Angelo A, Carraro G, Nobile M, Rigotti P, Bonfante L, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Crepaldi G (2001) Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 16:2111\u20132117","journal-title":"J Bone Miner Res"},{"key":"391_CR17","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0041-1345(02)02872-5","volume":"34","author":"M Koc","year":"2002","unstructured":"Koc M, Tuglular S, Arikan H, Ozener C, Akoglu E (2002) Alendronate increases bone mineral density in long-term renal transplant recipients. Transplant Proc 34:2111\u20132113","journal-title":"Transplant Proc"},{"key":"391_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00007890-200107150-00017","volume":"72","author":"DN Cruz","year":"2001","unstructured":"Cruz DN, Wysolmerski JJ, Brickel HM, Gundberg CG, Simpson CA, Mitnick MA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ (2001) Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 72:83\u201388","journal-title":"Transplantation"},{"key":"391_CR19","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0041-1345(03)00479-2","volume":"35","author":"JV Torregrosa","year":"2003","unstructured":"Torregrosa JV, Moreno A, Gutierrez A, Vidal S, Oppenheimer F (2003) Alendronate for treatment of renal transplant patients with osteoporosis. Transplant Proc 35:1393\u20131395","journal-title":"Transplant Proc"},{"key":"391_CR20","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1523-1755.2005.00306.x","volume":"67","author":"AE El-Agroudy","year":"2005","unstructured":"El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA (2005) A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int 67:2039\u20132045","journal-title":"Kidney Int"},{"key":"391_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.transproceed.2005.12.041","volume":"38","author":"E Nowacka-Cieciura","year":"2006","unstructured":"Nowacka-Cieciura E, Cieciura T, Baczkowska T, Kozi\u0144ska-Przyby\u0142 O, Tronina O, Chudzi\u0144ski W, Pacholczyk M, Durlik M (2006) Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. Transplant Proc 38:165\u2013167","journal-title":"Transplant Proc"},{"key":"391_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.transproceed.2011.01.025","volume":"43","author":"S Abediazar","year":"2011","unstructured":"Abediazar S, Nakhjavani MR (2011) Effect of alendronate on early bone loss of renal transplant recipients. Transplant Proc 43:565\u2013567","journal-title":"Transplant Proc"},{"key":"391_CR23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00774-004-0547-6","volume":"23","author":"Y Nishizawa","year":"2005","unstructured":"Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M, Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society (2005) Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab 23:97\u2013104","journal-title":"J Bone Miner Metab"},{"key":"391_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.32.1.56","volume":"32","author":"RB Payne","year":"1979","unstructured":"Payne RB, Carver ME, Morgan DB (1979) Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32:56\u201360","journal-title":"J Clin Pathol"},{"key":"391_CR25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"391_CR26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-6143.2002.020111.x","volume":"2","author":"DN Cruz","year":"2002","unstructured":"Cruz DN, Brickel HM, Wysolmerski JJ, Gundberg CG, Simpson CA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ (2002) Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate. Am J Transplant 2:62\u201367","journal-title":"Am J Transplant"},{"key":"391_CR27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1359\/jbmr.091025","volume":"25","author":"S Giannini","year":"2010","unstructured":"Giannini S, Sella S, Silva-Netto F, Cattelan C, Carbonare LD, Lazzarin R, Marchini F, Rigotti P, Marcocci C, Cetani F, Pardi E, D\u2019Angelo A, Realdi G, Bonfante L (2010) Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency. J Bone Miner Res 25:841\u2013848","journal-title":"J Bone Miner Res"},{"key":"391_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2010.12.024","volume":"49","author":"PD Miller","year":"2011","unstructured":"Miller PD (2011) The kidney and bisphosphonates. Bone 49:77\u201381","journal-title":"Bone"},{"key":"391_CR29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000187765","volume":"66","author":"MK Almonde","year":"1994","unstructured":"Almonde MK, Kwan JTC, Evans K, Cummingham J (1994) Loss of regional bone mineral density in the first 12\u00a0months following renal transplantation. Nephron 66:52\u201357","journal-title":"Nephron"},{"key":"391_CR30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.transproceed.2005.02.060","volume":"37","author":"J Toro","year":"2005","unstructured":"Toro J, Gentil MA, Garc\u00eda R, P\u00e9rez-Valdivia MA, Garc\u00eda Avellano E, Algarra GR, Pereira P, Gonz\u00e1lez-Roncero F, Mateos J (2005) Alendronate in kidney transplant patients: a single-center experience. Transplant Proc 37:1471\u20131472","journal-title":"Transplant Proc"},{"key":"391_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00774-004-0553-8","volume":"23","author":"Suzuki A OnoY","year":"2005","unstructured":"OnoY Suzuki A, Kotake M, Zhang X, Nishiwaki-Yasuda K, Ishiwata Y, Imamura S, Nagata M, Takamoto S, Itoh M (2005) Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in normal Japanese population. J Bone Miner Metab 23:147\u2013151","journal-title":"J Bone Miner Metab"},{"key":"391_CR32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1507\/endocrj.K06-001","volume":"53","author":"A Suzuki","year":"2006","unstructured":"Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N, Hashimoto S, Itoh M (2006) Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 53:503\u2013510","journal-title":"Endocr J"},{"key":"391_CR33","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1097\/01.ASN.0000093255.56474.B4","volume":"14","author":"AE El-Agroudy","year":"2003","unstructured":"El-Agroudy AE, El-Husseini AA, El-Sayed M, Ghoneim MA (2003) Preventing bone loss in renal transplant recipients with vitamin D. J Am Soc Nephrol 14:2975\u20132979","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-012-0391-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-012-0391-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-012-0391-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:21:44Z","timestamp":1714472504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-012-0391-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1007\/s00774-012-0391-z","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,18]]}}}